HomeCompareBVNKF vs MCD

BVNKF vs MCD: Dividend Comparison 2026

BVNKF yields 6.73% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $47.3K in total portfolio value· pulled ahead in Year 6
10 years
BVNKF
BVNKF
● Live price
6.73%
Share price
$29.71
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.2K
Annual income
$1,032.71
Full BVNKF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — BVNKF vs MCD

📍 MCD pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBVNKFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BVNKF + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BVNKF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVNKF
Annual income on $10K today (after 15% tax)
$572.20/yr
After 10yr DRIP, annual income (after tax)
$877.80/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $21,415.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVNKF + MCD for your $10,000?

BVNKF: 50%MCD: 50%
100% MCD50/50100% BVNKF
Portfolio after 10yr
$54.9K
Annual income
$13,630.21/yr
Blended yield
24.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

BVNKF
No analyst data
Altman Z
6.8
Piotroski
8/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVNKF buys
0
MCD buys
0
No recent congressional trades found for BVNKF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBVNKFMCD
Forward yield6.73%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$31.2K$78.5K
Annual income after 10y$1,032.71$26,227.70
Total dividends collected$8.6K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: BVNKF vs MCD ($10,000, DRIP)

YearBVNKF PortfolioBVNKF Income/yrMCD PortfolioMCD Income/yrGap
1$11,373$673.17$10,815$334.85+$558.00BVNKF
2$12,885$715.53$11,826$491.71+$1.1KBVNKF
3$14,544$757.60$13,123$730.06+$1.4KBVNKF
4$16,362$799.23$14,853$1,100.07+$1.5KBVNKF
5$18,347$840.27$17,257$1,690.61+$1.1KBVNKF
6← crossover$20,512$880.60$20,752$2,667.01$240.00MCD
7$22,868$920.10$26,103$4,354.83$3.2KMCD
8$25,428$958.68$34,794$7,437.78$9.4KMCD
9$28,204$996.24$49,926$13,461.60$21.7KMCD
10$31,211$1,032.71$78,550$26,227.70$47.3KMCD

BVNKF vs MCD: Complete Analysis 2026

BVNKFStock

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Full BVNKF Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this BVNKF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVNKF vs SCHDBVNKF vs JEPIBVNKF vs OBVNKF vs KOBVNKF vs MAINBVNKF vs YUMBVNKF vs QSRBVNKF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.